We recently published 10 Stocks With Eye-Popping Double-Digit Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is one of the biggest performers on Wednesday. Hims & Hers rallied for a second day on ...

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...

Hims & Hers Health (HIMS -1.19%) is a telehealth company that offers personalized solutions for its customers. And demand has been robust, with subscriptions for its products risi ...

Apostrophe is being shut down to "simplify its (company's) dermatology products and operations into one seamless experience," Hims & Hers said. The telehealth company, which also offers products for ...

Hims treatments are among the highest-rated in the UK, trusted by millions of men. They’re affordable too, starting from less than £1 per day, with up to 50% off your first order.

Hims & Hers (NYSE: HIMS) CEO Andrew Dudum isn't interested in taking insurance onto his platform, and that shows how disruptive the company could be. This could be the next great growth stock if ...

HIMS Price Action: Hims & Hers shares were up 1.26% at $49.58 at the time of publication Wednesday. The stock traded as high as $52.33 on Wednesday before pulling back.

10 stocks we like better than Hims & Hers Health When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor ...